i-Health launches Estroven Weight Management solution
CROMWELL, Conn. — i-Health on Monday unveiled its Estroven Weight Management, a supplement specifically formulated to address the physical changes of menopause plus deliver on a core benefit of helping peri/menopausal women manage their weight as they go through this stage of life.
As women enter menopause, estrogen levels in their body decrease, which factors into why many women find their weight more difficult to manage. “For many women, one of the most unexpected aspects of menopause is the sudden shift in weight,” stated Shari Brasner, Estroven spokeswoman. “Because the menopausal body decreases its production of estrogen, the processes involving insulin, leptin, ghrelin, serotonin and neuropeptide Y are affected. Estrogen influences energy expenditure as well as food intake, and as levels of this hormone decline, processes in the body that regulate weight also change.”
To combat this phenomenon, the ingredients in Estroven Weight Management, black cohosh and Synetrim CQ, a proprietary extract of Cissus quadrangularis, balance declining serotonin levels to help safely manage weight. Like other products in the Estroven line, Weight Management also includes clinically-proven soy isoflavones to help reduce hot flashes and night sweats.
“The formulation of Estroven Weight Management is in direct response to the overwhelming consensus from perimenopausal and menopausal women on the daily frustrations of managing their weight … on top of dealing with other symptoms,” stated April Mills, marketing director at i-Health. “We’re pleased to be able to offer the only retail product developed with naturally-sourced ingredients to provide safe, multi-symptom menopause relief for hot flashes and night sweats, plus weight management so women can ultimately feel like themselves again.”
Estroven Weight Management has a suggested retail price of $21.99.
i-Health will be supporting Estroven Weight Management with dedicated TV Creative on targeted cable programming such as Dr. Oz, The Food Network, HGTV, Lifetime, OWN and TV Land. There will also be a print campaign through Better Homes & Gardens, Good Housekeeping, Ladies Home Journal, Prevention and Woman’s Day magazines. And in addition to online banner ads, i-Health has developed an online destination Changing Ways where consumers can follow six bloggers who are on their eight-week journey trying new Weight Management and receive expert fitness and nutrition advice along with a $5 coupon to start their own journey. i-Health will also be supporting the launch with national and digital FSIs featuring a $3 coupon to incent trial.
Introduction of Estroven weight management system by i-health is a boon for health conscious people. It will help them to maintain their body weight as required. Being overweight and underweight is curse, maintain the desired weight level is the sign of healthy person. dr note
Improving the sub-par adherence report card
One of the most effective levers pharmacists and other health professionals can pull to curb the nation’s $2.7 trillion healthcare bill is boosting patients’ adherence to their prescription drug treatment regimens. But who’s holding the handle?
That’s one of the questions raised by a new study on patient adherence rates by the nation’s top independent pharmacy organization. In its first National Report Card on Adherence, the National Community Pharmacists Association gives U.S. adults ages 40 and older only a so-so grade of C+ overall, and says 1-in-7 of those medication users rate an F. “Millions of adults ages 40 and older with chronic conditions are departing from doctors’ instructions in taking their medications – skipping, missing or forgetting whether they’ve taken doses, failing to fill or refill prescriptions, under- or over-dosing, or taking medication prescribed for a different condition or to a different person,” NCPA reported.
Factors like the out-of-pocket cost of a prescription and the patient’s age — older patients tend to adhere more to their drug therapy than do younger ones — play a big part in adherence rates. And of course patients tend to skip their meds if they don’t want to deal with the side effects, or if they don’t perceive the drug’s long-term benefit. But in a big way, success in the campaign to boost adherence is about relationships, NCPA’s findings suggested. Patients who have a long-term, sustained relationship with a particular physician and/or pharmacist tend to stay on their medication regimens more than those who don’t.
“Adherence is higher among patients who see the same health care provider each time they have a medical appointment, compared with those who see the same provider less frequently,” the report says. “These results suggest the power of patient/provider relationships in prescription drug adherence.
“Feeling connected with the pharmacist or pharmacy staff or having a continuous relationship with a health care provider likely facilitates communication, boosting greater adherence among these groups.”
Critical to that effort is pharmacist involvement, or — to extend the analogy at the top of this blog — to make sure pharmacists can grab the lever and pull effectively. Says NCPA in its report, “Pharmacists have a role at the forefront of addressing prescription medication non-adherence. The results of this survey indicate that much depends on the extent to which pharmacists and pharmacy staff establish a personal connection with their customers and engage with them to encourage fuller understanding of the importance of taking medications as prescribed.”
To that end, NCPA asserts, “Independent pharmacists may be particularly well placed to boost adherence, given their greater personal connection with patients.”
Tens of thousands of dedicated and fully engaged chain pharmacists who have worked hard to establish rapport with their patients and build clinical-care programs might take issue with that assertion. As reported last week by Drug Store News associate editor Alaric DeArment, “The biggest predictor of patients’ adherence overall was their connection to pharmacists or pharmacy staff.”
Examples of collaborative programs among pharmacists and regional health organizations to boost adherence among specific groups of patients abound. Please share yours by clicking on the comment button, because sharing ideas and best practices can boost adherence efforts overall.
No comments found
Genentech adds BioPlus to limited-distribution network for Tarceva
ALTAMONTE SPRINGS, Fla. — BioPlus Specialty Pharmacy has been added to the limited-distribution network for a Genentech drug used to treat lung and pancreatic cancers.
BioPlus announced that it had become a distributor for the drug Tarceva (erlotinib) starting Monday, when the drug, made by Genentech and Astellas, ceased to be available in retail pharmacies.
"BioPlus has worked for many years with patients taking Tarceva, and we look forward to continuing to service oncology patients as one of the small number of specialty pharmacies with ongoing access to this limited drug," BioPlus director of pharmaceutical contract management Sharon Ferrer said.
No comments found